Tracking adiponectin biodistribution via fluorescence molecular tomography indicates increased vascular permeability after streptozotocin-induced diabetes

• Published in: American journal of physiology: endocrinology and metabolism Vol. 317; no. 5; pp. E760 - E772
• Main Authors: Yoon, Nanyoung, Dadson, Keith, Dang, Thanh, Chu, Teresa, Noskovicova, Nina, Hinz, Boris, Raignault, Adeline, Thorin, Eric, Kim, Seunggyu, Jeon, Jessie S, Jonkman, James, McKee, Trevor D, Grant, Justin, Peterson, Jeffrey D, Kelly, Scott P, Sweeney, Gary
• Format: Journal Article
• Language: English
• Published: United States American Physiological Society 01.11.2019
• Series: Translational Physiology
• Subjects: Adiponectin; Adiponectin - metabolism; Animals; Capillary Permeability; Cardiovascular diseases; Cell Line; Computed tomography; Diabetes; Diabetes mellitus; Diabetes Mellitus, Experimental - metabolism; Diabetes Mellitus, Experimental - pathology; Endothelial cells; Endothelial Cells - metabolism; Endothelium; Energy metabolism; Fluorescence; Gene Knockdown Techniques; Glucose; Glucose - pharmacology; Heart; Humans; Immunohistochemistry; Inserts; Liver - metabolism; Male; Menopause; Mice; Mice, Inbred C57BL; Microcirculation; Microfluidics; Microvasculature; Myocardium - metabolism; Permeability; Rats; Rats, Wistar; siRNA; Streptozocin; Tissue Distribution; Tissues; Tomography - methods; Tomography, X-Ray Computed; adiponectin; vascular permeability; diabetes; endothelial; fluorescence molecular tomography; heart
• ISSN: 0193-1849; 1522-1555
• DOI: 10.1152/ajpendo.00564.2018

Adiponectin, a highly abundant polypeptide hormone in plasma, plays an important role in the regulation of energy metabolism in a wide variety of tissues, as well as providing important beneficial effects in diabetes, inflammation, and cardiovascular disease. To act on target tissues, adiponectin must move from the circulation to the interstitial space, suggesting that vascular permeability plays an important role in regulating adiponectin action. To test this hypothesis, fluorescently labeled adiponectin was used to monitor its biodistribution in mice with streptozotocin-induced diabetes (STZD). Adiponectin was, indeed, found to have increased sequestration in the highly fenestrated liver and other tissues within 90 min in STZD mice. In addition, increased myocardial adiponectin was detected and confirmed using computed tomography (CT) coregistration. This provided support of adiponectin delivery to affected cardiac tissue as a cardioprotective mechanism. Higher adiponectin content in the STZD heart tissues was further examined by ex vivo fluorescence molecular tomography (FMT) imaging, immunohistochemistry, and Western blot analysis. In vitro mechanistic studies using an endothelial monolayer on inserts and three-dimensional microvascular networks on microfluidic chips further confirmed that adiponectin flux was increased by high glucose. However, in the in vitro model and mouse heart tissue, high glucose levels did not change adiponectin receptor levels. An examination of the tight junction (TJ) complex revealed a decrease in the TJ protein claudin (CLDN)-7 in high glucose-treated endothelial cells, and the functional significance of this change was underscored by increased endothelium permeability upon siRNA-mediated knockdown of . Our data support the idea that glucose-induced effects on permeability of the vascular endothelium contribute to the actions of adiponectin by regulating its transendothelial movement from blood to the interstitial space. These observations are physiologically significant and critical when considering ways to harness the therapeutic potential of adiponectin for diabetes.